Practices that charge sometimes hefty membership fees promise more personalized care. But the high costs and low patient volumes may limit access for everyone
The self-administered tests are sold over the counter, holding out the promise of safer gatherings. But interpreting results requires savvy
They could be reduced with targeted exercise and some technological innovations
Bills totaling $287,365.08 provide insights into the dysfunctional economics of American medicine
LSD and psilocybin increasingly show promise as mental health treatments. Now universities and companies are exploring their use in pain management
The strain from COVID will mean fewer resources and less attention on reducing carbon footprints
About 80 conditions can be described as autoimmune disorders, although definitions are still changing
One patient recounts her journey through a world of disabling symptoms, ineffective treatments and dismissive doctors
Experts weigh in on common questions about whether and when additional doses of coronavirus vaccines may be needed
An educational experiment used escape rooms and the undead to set the stage for a terrible situation that would become all too real
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens...
Using machine learning, researchers created a tool that might help doctors improve people’s healthy lifespan
It’s time to invest more in home-based care and nursing homes, increase workers’ pay and improve oversight
Amid a COVID surge in Africa, vaccine promises from richer nations are not enough to bring an early end to the pandemic, experts say
We must train providers to understand their unique needs in order to deliver affirming, compassionate treatment
Chronic inflammation and immune breakdown appear to be key reasons
By a vote of 7-2, the court declined to overturn the landmark health care law for the third time
Designers should show how well instruments perform across different populations
Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines
People older than 80 who waited 11 to 12 weeks for their second jab had higher peak antibody levels than did those who waited only three weeks
